Subtopic Deep Dive
Mitochondrial Dysfunction in NBIA Disorders
Research Guide
What is Mitochondrial Dysfunction in NBIA Disorders?
Mitochondrial dysfunction in NBIA disorders refers to impaired mitochondrial bioenergetics, iron-sulfur cluster biogenesis, and elevated oxidative stress caused by mutations in NBIA-associated genes like PANK2 and PLA2G6.
NBIA disorders feature neurodegeneration with brain iron accumulation due to genetic defects disrupting mitochondrial function (Gregory et al., 2008, 359 citations). Mutations in PANK2 alter coenzyme A synthesis and mitochondrial stability (Kotzbauer et al., 2005, 148 citations), while PLA2G6 defects cause membrane homeostasis disruption and ubiquitinated protein accumulation (Malik et al., 2008, 159 citations). Over 20 papers detail these mechanisms since 2005.
Why It Matters
Mitochondrial ROS overproduction in NBIA links to neurodegeneration pathways shared with Parkinson's and Alzheimer's (Angelova and Abramov, 2018, 724 citations). Iron imbalance from NBIA gene defects reveals therapeutic targets like antioxidants for metabolic rescue (Levi and Finazzi, 2014, 159 citations). Insights from mouse models of PLA2G6 mutations inform treatments for infantile neuroaxonal dystrophy (Shinzawa et al., 2008, 161 citations).
Key Research Challenges
Iron-Sulfur Cluster Defects
NBIA mutations impair iron-sulfur cluster biogenesis essential for mitochondrial enzymes (Gregory et al., 2008). This disrupts electron transport and increases oxidative damage. Levi and Finazzi (2014) highlight limited comprehension of iron's role in progression.
Coenzyme A Synthesis Failure
PANK2 mutations reduce mitochondrial coenzyme A, causing bioenergetic collapse (Kotzbauer et al., 2005). Mutant proteins show abnormal processing and stability. No effective rescue strategies exist yet.
Oxidative Stress Amplification
Mitochondrial ROS drives axonal spheroids and neurodegeneration in NBIA (Angelova and Abramov, 2018). PLA2G6 defects exacerbate ubiquitinated protein buildup (Malik et al., 2008). Antioxidant testing in models yields inconsistent results.
Essential Papers
Role of mitochondrial <scp>ROS</scp> in the brain: from physiology to neurodegeneration
Plamena R. Angelova, Andrey Y. Abramov · 2018 · FEBS Letters · 724 citations
Mitochondria are key cell organelles in that they are responsible for energy production and control many processes from signalling to cell death. The function of the mitochondrial electron transpor...
Clinical and genetic delineation of neurodegeneration with brain iron accumulation
Allison Gregory, Brenda J. Polster, Susan J. Hayflick · 2008 · Journal of Medical Genetics · 359 citations
Neurodegeneration with brain iron accumulation (NBIA) describes a group of progressive neurodegenerative disorders characterised by high brain iron and the presence of axonal spheroids, usually lim...
Neuroacanthocytosis Syndromes
Hans H. Jung, Adrian Danek, Ruth H. Walker · 2011 · Orphanet Journal of Rare Diseases · 172 citations
Neuroaxonal Dystrophy Caused by Group VIA Phospholipase A<sub>2</sub>Deficiency in Mice: A Model of Human Neurodegenerative Disease
Koei Shinzawa, Hisae Sumi, Masahito Ikawa et al. · 2008 · Journal of Neuroscience · 161 citations
Calcium-independent group VIA phospholipase A 2 (iPLA 2 β) is considered to play a role in signal transduction and maintenance of homeostasis or remodeling of membrane phospholipids. A role of iPLA...
Disrupted Membrane Homeostasis and Accumulation of Ubiquitinated Proteins in a Mouse Model of Infantile Neuroaxonal Dystrophy Caused by PLA2G6 Mutations
Ibrahim Malik, John Turk, David J. Mancuso et al. · 2008 · American Journal Of Pathology · 159 citations
Neurodegeneration with brain iron accumulation: update on pathogenic mechanisms
Sonia Levi, Dario Finazzi · 2014 · Frontiers in Pharmacology · 159 citations
Perturbation of iron distribution is observed in many neurodegenerative disorders, including Alzheimer's and Parkinson's disease, but the comprehension of the metal role in the development and prog...
Insights on the interaction of alpha-synuclein and metals in the pathophysiology of Parkinson's disease
Eleonora Carboni, Paul Lingor · 2015 · Metallomics · 159 citations
The interaction of different metals with the Parkinson's disease-associated protein alpha-synuclein results in oxidative stress, protein aggregation and pathology progression.
Reading Guide
Foundational Papers
Start with Gregory et al. (2008, 359 citations) for NBIA genetics and clinical scope, then Kotzbauer et al. (2005, 148 citations) for PANK2 mitochondrial mechanisms, followed by Shinzawa et al. (2008, 161 citations) and Malik et al. (2008, 159 citations) for PLA2G6 models.
Recent Advances
Study Levi et al. (2024, 139 citations) on iron imbalance; Dušek et al. (2022, 139 citations) on cerebral iron deposition; Angelova and Abramov (2018, 724 citations) for ROS in neurodegeneration.
Core Methods
Coenzyme A assays and stability tests (Kotzbauer et al., 2005); mouse PLA2G6 knockouts for dystrophy (Shinzawa et al., 2008); ROS imaging and iron quantification in cellular models (Angelova and Abramov, 2018; Levi and Finazzi, 2014).
How PapersFlow Helps You Research Mitochondrial Dysfunction in NBIA Disorders
Discover & Search
Research Agent uses searchPapers and citationGraph to map NBIA mitochondrial papers from PANK2 and PLA2G6 hubs, revealing Gregory et al. (2008, 359 citations) as a central node linking to 50+ related works. exaSearch uncovers recent iron-mitochondria overlaps, while findSimilarPapers expands from Angelova and Abramov (2018).
Analyze & Verify
Analysis Agent applies readPaperContent to extract PANK2 mutation effects from Kotzbauer et al. (2005), then verifyResponse with CoVe checks claims against Levi et al. (2024). runPythonAnalysis processes ROS data from Angelova and Abramov (2018) for statistical verification; GRADE grading scores evidence strength for NBIA models.
Synthesize & Write
Synthesis Agent detects gaps in antioxidant therapies across NBIA papers, flagging contradictions between PLA2G6 mouse models (Shinzawa et al., 2008; Malik et al., 2008). Writing Agent uses latexEditText, latexSyncCitations, and latexCompile to draft review sections; exportMermaid visualizes iron homeostasis pathways.
Use Cases
"Analyze ROS levels and mitochondrial defects in PANK2 NBIA models from recent papers."
Research Agent → searchPapers('PANK2 mitochondrial dysfunction NBIA') → Analysis Agent → runPythonAnalysis (pandas/matplotlib on extracted datasets from Kotzbauer et al., 2005) → statistical plots of coenzyme A decline.
"Draft LaTeX review on PLA2G6 mutations and brain iron in NBIA."
Synthesis Agent → gap detection (Malik et al., 2008 vs Shinzawa et al., 2008) → Writing Agent → latexEditText + latexSyncCitations (Gregory et al., 2008) + latexCompile → formatted PDF with cited figures.
"Find code for NBIA mitochondrial simulations from papers."
Research Agent → paperExtractUrls (Levi and Finazzi, 2014) → paperFindGithubRepo → githubRepoInspect → executable Python models of iron-sulfur biogenesis.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ NBIA papers: searchPapers → citationGraph → GRADE all claims → structured report on mitochondrial targets. DeepScan applies 7-step analysis to PLA2G6 models (Shinzawa et al., 2008), with CoVe checkpoints verifying ROS data. Theorizer generates hypotheses linking PANK2 defects to Parkinson's iron pathways from Kotzbauer et al. (2005).
Frequently Asked Questions
What defines mitochondrial dysfunction in NBIA?
NBIA gene mutations like PANK2 and PLA2G6 impair coenzyme A synthesis, iron-sulfur clusters, and ROS control, leading to bioenergetic failure and neurodegeneration (Gregory et al., 2008).
What are key methods studying NBIA mitochondria?
Mouse models test PLA2G6 deficiencies for membrane defects (Shinzawa et al., 2008; Malik et al., 2008); biochemical assays measure coenzyme A and ROS (Kotzbauer et al., 2005; Angelova and Abramov, 2018).
What are seminal papers on NBIA mitochondria?
Gregory et al. (2008, 359 citations) delineates NBIA genetics; Kotzbauer et al. (2005, 148 citations) details PANK2 mitochondrial effects; Levi and Finazzi (2014, 159 citations) updates mechanisms.
What open problems persist in NBIA mitochondrial research?
Therapeutic rescue of iron-sulfur biogenesis lacks validation; antioxidant efficacy varies across NBIA subtypes; links to common diseases like Parkinson's need clinical trials (Levi et al., 2024).
Research Neurological diseases and metabolism with AI
PapersFlow provides specialized AI tools for Neuroscience researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Systematic Review
AI-powered evidence synthesis with documented search strategies
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Mitochondrial Dysfunction in NBIA Disorders with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Neuroscience researchers